Hong Kong Stock Exchange · 1801

Innovent Biologics, Inc. price

Price history, key statistics, and comparable assets for Innovent Biologics, Inc..

HK$94.85

+4.29% (HK$3.90)

HKD cached quoteYahoo Finance

Historical prices

Price history

Intraday through long-term closing prices. Choose 1 day, 1 week, 1 month, 6 months, year to date, 1 year, 5 years, or all available history.

Price chart range

1Y daily closing price

HK$94.85

Up +3.77% over 1Y

Range low
HK$72.95
Range high
HK$107.00

Use the left and right arrow keys to inspect prices. On a touch screen, tap the chart to inspect the nearest point.

1Y daily closing-price chart, up 3.77 percent

7 Aug 20257 Aug 2026

Point-in-time fields

Key statistics

Previous close
HK$90.95
Open
HK$90.05
Day range
HK$89.55 to HK$94.95
52-week range
HK$69.55 to HK$109.10
Volume
18.14M
Average volume
10.79M
Market cap
165.39B
P/E ratio (TTM)
183.92

Profile

About Innovent Biologics, Inc.

Innovent Biologics, Inc. trades on Hong Kong Stock Exchange under 1801 and is grouped under Health Technology. Figures marked unavailable are not estimated.

Contextual peers

1801 questions

Innovent Biologics, Inc. questions

What is the 1801 stock price?

Innovent Biologics, Inc. (1801) had a cached quote of HK$94.85 as of 2026-08-07T08:08:11.000Z. Market prices move, so this is not an execution quote.

Where does Glide get 1801 stock data?

Glide uses Yahoo Finance market data. Quotes and daily history are cached with the original market timestamp, and visiting this page does not contact Yahoo Finance.

Can I access 1801 through Glide?

Glide does not list a tokenized 1801 product in its current asset registry. This market-data page does not imply that the stock is tradeable on Glide.

Risk and data disclosure

Read before using this data

Glide provides this market data for informational purposes only. It is not investment advice, a recommendation, or an offer to buy or sell any asset. Prices may be delayed or incomplete. Verify market data and consider your objectives, financial situation, and professional advice before acting.

View Yahoo Finance source record